Literature DB >> 24195483

Introducing new vaccines in developing countries.

Sonali Kochhar1, Barbara Rath, Lea D Seeber, Gabriella Rundblad, Ali Khamesipour, Mohammad Ali.   

Abstract

Vaccines offer the most cost-effective approach to controlling infectious diseases. Access to vaccines remains unequal and suboptimal, particularly in poorer developing countries. Introduction of new vaccines and long-term sustainability of immunization programs will require proactive planning from conception to implementation. International and national coordination efforts as well as local and cultural factors need to be known and accounted for. Adequate infrastructure should be in place for the monitoring of disease burden, vaccine effectiveness and vaccine safety, based on the common terminology and international consensus. This overview paper aims to raise awareness of the importance of introduction efforts for vaccines of special relevance to resource-poor countries. The target audiences are those involved in immunization programs, from planning or oversight roles to frontline providers, as well as health care professionals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24195483     DOI: 10.1586/14760584.2013.855612

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  11 in total

1.  A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact.

Authors:  Kristina Jonsson-Schmunk; Maria A Croyle
Journal:  Expert Rev Anti Infect Ther       Date:  2015-03-23       Impact factor: 5.091

2.  Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities.

Authors:  Bondi Arifin; Titik Anas
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

3.  Ebola vaccine development plan: ethics, concerns and proposed measures.

Authors:  Morenike Oluwatoyin Folayan; Aminu Yakubu; Bridget Haire; Kristin Peterson
Journal:  BMC Med Ethics       Date:  2016-02-08       Impact factor: 2.652

4.  A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon.

Authors:  Andrew W Taylor-Robinson
Journal:  Res Rep Trop Med       Date:  2016-07-05

Review 5.  Prospects on the Use of Schizochytrium sp. to Develop Oral Vaccines.

Authors:  Abel Ramos-Vega; Sergio Rosales-Mendoza; Bernardo Bañuelos-Hernández; Carlos Angulo
Journal:  Front Microbiol       Date:  2018-10-25       Impact factor: 5.640

Review 6.  Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations.

Authors:  Sonali Kochhar; Kathryn M Edwards; Alba Maria Ropero Alvarez; Pedro L Moro; Justin R Ortiz
Journal:  Vaccine       Date:  2019-05-06       Impact factor: 3.641

7.  Trends in vaccine investment in middle income countries.

Authors:  K Onishchenko; S Hill; M Wasserman; C Jones; M Moffatt; L Ruff; S J Pugh
Journal:  Hum Vaccin Immunother       Date:  2019-04-12       Impact factor: 3.452

Review 8.  'Learn from the lessons and don't forget them': identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns.

Authors:  Julie Collins; Rosie Westerveld; Kate A Nelson; Hana Rohan; Hilary Bower; Siobhan Lazenby; Gloria Ikilezi; Rebecca Bartlein; Daniel G Bausch; David S Kennedy
Journal:  BMJ Glob Health       Date:  2021-09

9.  Are Parent-Held Child Health Records a Valuable Health Intervention? A Systematic Review and Meta-Analysis.

Authors:  Muhammad Chutiyami; Shirley Wyver; Janaki Amin
Journal:  Int J Environ Res Public Health       Date:  2019-01-14       Impact factor: 3.390

10.  Advancing challenges in Paediatric Virology: An interview with Professor Barbara A. Rath, Co-founder and Chair of the Vienna Vaccine Safety Initiative.

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2019-08-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.